AUG 20 - 21 2014
Genetics and Genomics
958 40 157748

The theme of this conference is a range of genetics and genomics topics such as Bioinformatics and Quantitative Genomics, Cancer Detection, Cancer Genomics, Clinical Genomics, Complex Diseases, Environmental Genomics, Epidemiology and Population Genetics, Epigenetics/Epigenomics, FDA, Regulatory, Law, Gene expression, Gene Therapy, Genetics and Genomics Testing, Genomic medicine, Genomics of IPS cell lines, Post-GWAS-era, Precision Medicine, Prenatal, Prokaryotic Genetics, Sequencing or NGS, Synthetic and Systems Biology, Translational and Discovery Genomics and much more. Attendees can earn free CME, CE and CEU Credits.

The learning objectives for this conference are as follows:
 

  • Ability to contrast previous and newly released guidelines
  • Take action to increase partnership and collaboration with clinicians
  • Identify actions that can be taken to deliver quality results faster to clinicians
  • Better define personalized healthcare today and explain the role of companion diagnostics
  • Better describe diagnostic tools used in the patient workups
  • Better describe how the evolution of laboratory testing in health has impacted the patient
  • Provide screening, diagnosis and monitoring technologies presently in the clinical laboratory.
  • Demonstrate the different types of laboratory testing.
  • Explain how testing is used in diagnosis.
  • Identify the role of the clinical laboratory in contributing to or preventing diagnostic errors
  • Identify laboratory directed interventions that can reduce diagnostic errors


This event will bring together research scientists, post docs, principal investigators, lab directors and professionals from around the world to learn about recent advances in genetics and genomics. This conference offers an amazing opportunity as it is free to participants, and there will be no out-of-pocket expenses for travel. However, participants will still benefit from interacting with a global community of like-minded colleagues, without leaving the comfort of their office or home.

Conference participants will be able to

 

 

  • Attend interactive live streaming video sessions
  • Have their questions answered in real-time by industry experts
  • Chat live with peers and speakers
  • Browse a virtual exhibit floor for solution providers


No crowded airports, delayed flights or expensive hotel rooms, but still the look and feel of a first-rate conference with world renowned experts. Participants also benefit from the fact that experts and vendors are more accessible, no more waiting in line to speak to someone. Think it is too good to be true? Checkout the venue and become a believer.

 

 


Speakers:
  • Department Chair, Department of Systems Biology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center
  • Professor and Chair, Department of Genetics, Director, Heflin Center for Genomic Sciences, UAB
  • Core Faculty Member, The Broad Institute of MIT/Harvard, Investigator, McGovern Institute for Brain Research, W.M. Keck Career Development Professor of Biomedical Engineering Assistant Profes
  • Research Associate, Genome Institute of Singapore (GIS), A*STAR
  • Founder & President, Rare Genomics Institute, School Faculty Member, Washington University in St. Louis
  • Associate Director for Population Sciences, Professor of Community and Family Medicine at the Geisel School of Medicine, Norris Cotton Cancer Center, Dartmouth College
  • Director of Computational Sciences and Informatics program for Complex Adaptive Systems and Professor in the School of Life Sciences, Arizona State University
  • GIS fellow, Genome Institute of Singapore, A*STAR, Genome Institute of Singapore
  • Director, Division of Genomic Technologies, RIKEN Center for Life Science Technologies
  • Assistant Professor, Harvard Medical School, Assistant Scientist, Schepens Eye Research Institute, Massachusetts Eye and Ear
  • Assistant Director, University of Iowa - Iowa Institute for Human Genetics
  • President, Coastal Genomics
  • Clinical Molecular Genetics Fellow, Partners HealthCare Personalized Medicine
  • Instructor of Pathology, BWH and Harvard Medical School,  Assistant Laboratory Director and Senior IS Domain Specialist Laboratory for Molecular Medicine, Partners HealthCare Center for Perso
  • Vice President and Distinguished Scientist Illumina
  • Postdoctoral researcher, HHMI research associate, Departments of Bioengineering and Applied Physics, Stanford University
  • Senior Manager, NGS Applications, DNASTAR
  • Clinical Professor, UCSF School of Medicine; Chief Medical Officer, Invitae Corp
  • Senior Scientist, Synthetic Biology Group, J. Craig Venter Institution
  • Professor of Computational Biology and Bioinformatics, Department of Biostatistics, Harvard University, Dana-Farber Cancer Institute
  • Director of OncoScan Product Marketing Strategy, Affymetrix
  • Assistant Professor of Chemical and Biological Engineering, Northwestern University
  • Assistant Professor, Department of Systems & Computational Biology, Assistant Professor, Department of Epidemiology & Population Health, Albert Einstein College of Medicine
  • CEO, CSO and Co-Founder, AllSeq, Inc.
  • Founder and CEO, Gene Counsel
  • Professor, Scientific Director, Head of MSc program in Biotechnology, Tel Hai College, GGA - Galil Genetic Analysis
  • Senior Researcher, Uppsala University, Centre for Research Ethics & Bioethics
  • Assistant Professor Department of Molecular Virology, Immunology and Medical Genetics, Assistant Professor, Division of Hematology, Department of Internal Medicine, Human Cancer Genetics Prog
  • Chief Scientific Officer, Pacific Biosciences
  • Albert L. Williams Professor of Biomedical Informatics, Co-Director, Yale Computational biology and Bioinformatics Program, Yale University
  • Department Chair, Department of Systems Biology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center
  • Joanna Hamilton, PhD, Co-Director, Dartmouth Medical School and the Norris Cotton Cancer Center Lynne Apone, PhD, Application and Product Development Scientist, NEBNext group, New England Bi
  • Assistant Professor, Department of Computational Medicine & Bioinformatics, Assistant Professor, Department of Human Genetics, University of Michigan
  • Director, Head of Biological research content, Qiagen, Inc.
  • Field Application Scientist, Ingenuity Systems, a Qiagen company, Neihaus research fellow, Memorial Sloan Kettering Cancer Center
  • Research Professor of Epidemiology, Emory University

Show Resources
Agenda
All times are Pacific Time
  • AUG 20, 2014 07:00 AM PDT
    Speaker: Mark B Gerstein, PhD
  • AUG 20, 2014 07:15 AM PDT
    Speaker: Michael C Jewett, PhD
  • AUG 20, 2014 07:30 AM PDT
    Speaker: Joanna Hamilton, PhD, Lynne Apone, PhD, Zach Smith, MS
    SEE ABSTRACT | Continuing Education: CEU
  • AUG 20, 2014 08:00 AM PDT
    Speaker: Ryan E Mills, PhD
    SEE ABSTRACT | Continuing Education: CEU
  • AUG 20, 2014 08:00 AM PDT
    Speaker: David E Symer, MD, PhD
  • AUG 20, 2014 08:30 AM PDT
    Speaker: Vikram Devgan, PhD, MBA
  • AUG 20, 2014 08:45 AM PDT
    Speaker: John Glass, PhD
    SEE ABSTRACT | Continuing Education: CEU
  • AUG 20, 2014 08:45 AM PDT
    Speaker: Dani Bercovich, PhD
    SEE ABSTRACT | Continuing Education: CEU
  • AUG 20, 2014 10:30 AM PDT
    Speaker: Sohela Shah, PhD
    SEE ABSTRACT | Continuing Education: CEU
  • AUG 20, 2014 10:45 AM PDT
    Speaker: Padma Sundar, MBA, MPH
    SEE ABSTRACT | Continuing Education: CEU
  • AUG 20, 2014 11:30 AM PDT
    Speaker: Jonas Korlach, PhD
    SEE ABSTRACT | Continuing Education: CEU
  • AUG 20, 2014 11:45 AM PDT
    Speaker: Heidi C Howard, PhD
    SEE ABSTRACT | Continuing Education: CEU
  • AUG 20, 2014 11:45 AM PDT
    Speaker: Ellen T Matloff, MS, CGC
  • AUG 20, 2014 02:15 PM PDT
    Speaker: Jessica C Mar, PhD
    SEE ABSTRACT | Continuing Education: CEU
  • AUG 21, 2014 06:45 AM PDT
    Speaker: Feng Zhang, PhD
  • AUG 21, 2014 06:45 AM PDT
    Speaker: Heather McLaughlin, PhD, MB(ASCP)CM
  • AUG 21, 2014 08:45 AM PDT
    Speaker: Jimmy Lin, MD, PhD, MHS
    SEE ABSTRACT | Continuing Education: CEU
  • AUG 21, 2014 08:45 AM PDT
    From Genetics to Genetic Medicine: Gene Therapy for vision restoration as a case study
    Speaker: Luk H Vandenberghe, PhD
  • AUG 21, 2014 08:45 AM PDT
    Speaker: Matthew Lebo, PhD, FACMG
    SEE ABSTRACT | Continuing Education: CEU
  • AUG 21, 2014 09:30 AM PDT
    Speaker: Gary Schroth,PhD
    SEE ABSTRACT | Continuing Education: CEU
  • AUG 21, 2014 09:45 AM PDT
    Speaker: Christopher I Amos, PhD
    SEE ABSTRACT | Continuing Education: CEU
  • AUG 21, 2014 09:45 AM PDT
    Speaker: Iwijn De Vlaminck, PhD
    SEE ABSTRACT | Continuing Education: CEU
  • AUG 21, 2014 10:45 AM PDT
    Speaker: Colleen Campbell, PhD
    SEE ABSTRACT | Continuing Education: CEU
  • AUG 21, 2014 11:15 AM PDT
    Speaker: Bruce R Korf, MD, PhD
  • AUG 21, 2014 11:30 AM PDT
    Automation of High Throughput Agarose Gel Electrophoresis with the NIMBUS Select Featuring Ranger Technology
    Speaker: Matthew Nesbitt, MSc
  • AUG 21, 2014 11:30 AM PDT
    Speaker: Kenneth Buetow, PhD, FACMI
  • AUG 21, 2014 12:15 PM PDT
    Speaker: Matthew Keyser, MS
    SEE ABSTRACT | Continuing Education: CEU
  • AUG 21, 2014 12:45 PM PDT
    Speaker: Cecile Janssens, PhD
    SEE ABSTRACT | Continuing Education: CEU
  • AUG 21, 2014 02:30 PM PDT
    Speaker: Asif Javed, PhD
    SEE ABSTRACT | Continuing Education: CEU
  • AUG 21, 2014 03:00 PM PDT
    Unexpected Findings from Analysis of Complex Mammalian Transcriptomes
  • Keynote
  • AUG 21, 2014 11:15 AM PDT
    Speaker: Bruce R Korf, MD, PhD
  • Precision Medicine
  • Human Genome
  • AUG 20, 2014 07:00 AM PDT
    Speaker: Mark B Gerstein, PhD
  • Cell Biology
  • AUG 20, 2014 07:15 AM PDT
    Speaker: Michael C Jewett, PhD
  • Sequencing
  • AUG 20, 2014 07:30 AM PDT
    Speaker: Joanna Hamilton, PhD, Lynne Apone, PhD, Zach Smith, MS
    SEE ABSTRACT | Continuing Education: CEU
  • AUG 20, 2014 08:00 AM PDT
    Speaker: Ryan E Mills, PhD
    SEE ABSTRACT | Continuing Education: CEU
  • AUG 20, 2014 08:30 AM PDT
    Speaker: Vikram Devgan, PhD, MBA
  • AUG 20, 2014 10:30 AM PDT
    Speaker: Sohela Shah, PhD
    SEE ABSTRACT | Continuing Education: CEU
  • AUG 21, 2014 06:45 AM PDT
    Speaker: Heather McLaughlin, PhD, MB(ASCP)CM
  • AUG 21, 2014 08:45 AM PDT
    Speaker: Matthew Lebo, PhD, FACMG
    SEE ABSTRACT | Continuing Education: CEU
  • AUG 21, 2014 09:30 AM PDT
    Speaker: Gary Schroth,PhD
    SEE ABSTRACT | Continuing Education: CEU
  • AUG 21, 2014 09:45 AM PDT
    Speaker: Iwijn De Vlaminck, PhD
    SEE ABSTRACT | Continuing Education: CEU
  • AUG 21, 2014 12:15 PM PDT
    Speaker: Matthew Keyser, MS
    SEE ABSTRACT | Continuing Education: CEU
  • AUG 21, 2014 12:45 PM PDT
    Speaker: Cecile Janssens, PhD
    SEE ABSTRACT | Continuing Education: CEU
  • Human Genetics
  • AUG 20, 2014 08:00 AM PDT
    Speaker: David E Symer, MD, PhD
  • AUG 20, 2014 11:30 AM PDT
    Speaker: Jonas Korlach, PhD
    SEE ABSTRACT | Continuing Education: CEU
  • Synthetic and Systems Biology
  • AUG 20, 2014 08:45 AM PDT
    Speaker: John Glass, PhD
    SEE ABSTRACT | Continuing Education: CEU
  • Genetic Testing
  • AUG 20, 2014 08:45 AM PDT
    Speaker: Dani Bercovich, PhD
    SEE ABSTRACT | Continuing Education: CEU
  • AUG 20, 2014 11:45 AM PDT
    Speaker: Heidi C Howard, PhD
    SEE ABSTRACT | Continuing Education: CEU
  • AUG 21, 2014 11:30 AM PDT
    Automation of High Throughput Agarose Gel Electrophoresis with the NIMBUS Select Featuring Ranger Technology
    Speaker: Matthew Nesbitt, MSc
  • Cancer Genetics
  • AUG 20, 2014 10:45 AM PDT
    Speaker: Padma Sundar, MBA, MPH
    SEE ABSTRACT | Continuing Education: CEU
  • Genetic and Genomic Medicine
  • Genetic Counceling, FDA, Regulatory, Law
  • AUG 20, 2014 11:45 AM PDT
    Speaker: Ellen T Matloff, MS, CGC
  • AUG 21, 2014 10:45 AM PDT
    Speaker: Colleen Campbell, PhD
    SEE ABSTRACT | Continuing Education: CEU
  • Bioinformatics and Quantitative Genomics
  • AUG 21, 2014 06:45 AM PDT
    Speaker: Feng Zhang, PhD
  • AUG 21, 2014 02:30 PM PDT
    Speaker: Asif Javed, PhD
    SEE ABSTRACT | Continuing Education: CEU
  • Gene Expression
  • AUG 20, 2014 02:15 PM PDT
    Speaker: Jessica C Mar, PhD
    SEE ABSTRACT | Continuing Education: CEU
  • AUG 21, 2014 03:00 PM PDT
    Unexpected Findings from Analysis of Complex Mammalian Transcriptomes
  • Clinical Genomics
  • AUG 21, 2014 08:45 AM PDT
    Speaker: Jimmy Lin, MD, PhD, MHS
    SEE ABSTRACT | Continuing Education: CEU
  • Gene Therapy
  • AUG 21, 2014 08:45 AM PDT
    From Genetics to Genetic Medicine: Gene Therapy for vision restoration as a case study
    Speaker: Luk H Vandenberghe, PhD
  • Complex Diseases
  • AUG 21, 2014 09:45 AM PDT
    Speaker: Christopher I Amos, PhD
    SEE ABSTRACT | Continuing Education: CEU
  • AUG 21, 2014 11:30 AM PDT
    Speaker: Kenneth Buetow, PhD, FACMI
Speakers

  • Gordon B Mills, MD, PhD
    Department Chair, Department of Systems Biology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center
    Biography
      Gordon B. Mills, MD, PhD, was recruited to The University of Texas M. D. Anderson Cancer Center in 1994, where he holds the rank of Professor with joint appointments in Systems Biology, Breast Medical Oncology and Immunology; serves as chairman of the Department of Systems Biology; head of the section of Molecular Therapeutics and holds the Wiess Distinguished University Chair in Cancer Medicine. Dr. Mills is co-Director of the Kleberg Center for Molecular Markers and Director for the Gita and Ali Saberioon Molecular Markers building. This Center is responsible for developing personalized molecular medicine at MDACC. Dr. Mills has published extensively on the molecular analysis of cancer and currently serves as principal investigator or project investigator on many national peer review grants including NIH/NCI SPOREs and PPGs, Department of Defense, and Komen Foundation grants, and is a collaborator on multiple other national grants. Dr. Mills also holds more than 20 patents related to novel technologies and molecular markers and has co-founded an early diagnostics company. He currently sits on the scientific advisory boards of multiple companies and venture capital groups. Based on his expertise in technology development, he is the head of the M. D. Anderson Cancer Center Technology Review Committee.    
    • Bruce R Korf, MD, PhD
      Professor and Chair, Department of Genetics, Director, Heflin Center for Genomic Sciences, UAB
      Biography
        Dr. Korf is Wayne H. and Sara Crews Finley Chair in Medical Genetics, Professor and Chair of the Department of Genetics, Director of the Heflin Center for Genomic Sciences at UAB, and Co-Director of the UAB-HudsonAlpha Center for Genomic Medicine. He is a medical geneticist, pediatrician, and child neurologist, certified by the American Board of Medical Genetics (clinical genetics, clinical cytogenetics, clinical molecular genetics), American Board of Pediatrics, and American Board of Psychiatry and Neurology (child neurology). Dr. Korf is past president of the Association of Professors of Human and Medical Genetics, past president of the American College of Medical Genetics and Genomics, and current president of the ACMG Foundation for Genetic and Genomic Medicine. He has served on the Board of Scientific Counselors of the National Cancer Institute and the National Human Genome Research Institute at the NIH. He chairs the Medical Advisory Committee of the Children's Tumor Foundation and serves on the CTF Board of Directors. His major research interests are molecular diagnosis of genetic disorders and the natural history, genetics, and treatment of neurofibromatosis. He serves as principal investigator of the Department of Defense funded Neurofibromatosis Clinical Trials Consortium. He is co-author of Human Genetics and Genomics (medical student textbook, now in fourth edition), Medical Genetics at a Glance (medical student textbook, now in third edition), Emery and Rimoin's Principles and Practice of Medical Genetics (now in 6th edition), and Current Protocols in Human Genetics.
      • Feng Zhang, PhD
        Core Faculty Member, The Broad Institute of MIT/Harvard, Investigator, McGovern Institute for Brain Research, W.M. Keck Career Development Professor of Biomedical Engineering Assistant Profes
        Biography
          Feng Zhang is a Core Member of the Broad Institute of MIT and Harvard and the W. M. Keck Career Development Professor of Biomedical Engineering at MIT. As a graduate student at Stanford University, Zhang worked with advisor Karl Deisseroth to invent a set of technologies for dissecting the functional organization of brain circuits. His lab works on developing and applying disruptive technologies including optogenetics and genome engineering (TALEs and CRISPR) to understand nervous system function and disease. Zhang's long-term goal is to develop novel therapeutic strategies for disease treatment. He obtained a bachelor's degree from Harvard University and a PhD in chemistry and bioengineering from Stanford University. Before joining the MIT faculty he was a junior fellow of the Harvard University Society of Fellows. He is a recipient of the NSF's Alan T. Waterman Award, Perl/UNC Prize in Neuroscience, the NIH Director's Pioneer award, and awards from the Searle Scholars Program, McKnight, Keck, and Damon Runyon foundations.
        • Asif Javed, PhD
          Research Associate, Genome Institute of Singapore (GIS), A*STAR
          Biography
            Asif Javed received his PhD in Computer Science from Rensselaer Polytechnic Institute in 2008 working in population genomics. He then joined IBM TJ Watson Research Center as a postdoctoral researcher where his work was part of the Genographic project. In 2011, Dr Javed joined Genome Institute of Singapore, A*STAR as a research associate where his work focuses on rare disorder analysis and cancer genomics. He is currently applying the computational algorithms he has developed to elucidate the genetic cause of Mendelian disorders in multiple families.
          • Jimmy Lin, MD, PhD, MHS
            Founder & President, Rare Genomics Institute, School Faculty Member, Washington University in St. Louis
            Biography
              Jimmy Lin, MD, PhD, MHS, is a 2012 TED Fellow and Founder & President of Rare Genomics Institute, the world's first platform to enable any community to leverage cutting-edge biotechnology to advance understanding of any rare disease. Partnering with 18 of the top medical institutions, such as Harvard, Yale, Johns Hopkins, and Stanford, RGI helps custom design personalized research projects for diseases so rare that no organization exists to help. Dr. Lin is also a medical school faculty member at the Washington University in St. Louis and led the computational analysis of the first ever exome sequenching studies for any human disease at Johns Hopkins. He has numerous publications in Science, Nature, Cell, Nature Genetics, and Nature Biotechnology, and has been featured in Forbes, Bloomberg, Wall Street Journal, Washington Post, and the Huffington Post.
            • Christopher I Amos, PhD
              Associate Director for Population Sciences, Professor of Community and Family Medicine at the Geisel School of Medicine, Norris Cotton Cancer Center, Dartmouth College
              Biography
                Dr. Amos moved in September, 2012 to the Geisel School of Medicine, where he is leading the Center for Genomic Medicine and serving as the Associate Cancer Center Director for Population Studies. Dr. Amos is leading studies to identify genetic risk factors for lung cancer and melanoma risk using genome-wide association and sequencing approaches. Dr. Amos leads a U19 grant entitled Transdisciplinary Research in Cancer of the Lung (TRICL) to identify genetic factors for lung cancer and interactions with smoking, study these factors in cell biological and animal models and to perform epidemiological studies of gene and environmental contributions to lung cancer risk. This grant includes 16 subcontracts and integrates work from an international consortium. Dr. Amos has served as the leader of the biostatistics core for the Genetic Epidemiology of Lung Cancer Consortium (GELCC) since its inception. With the move to Dartmouth he has replicated the computing environment that manages studies for GELCC and TRICL. Dr. Amos also provides direction for a grant that characterizes and sequences nicotinic receptors and uses fMRI to investigate effects of nicotinic receptor variants on responses to smoking cues. Dr. Amos has also worked extensively in the genetic epidemiology of colon cancer. He developed a Peutz-Jeghers syndrome registry while at M.D. Anderson Cancer Center. He has also studied genetic risk factors for sporadic colon cancer and hereditary nonpolyposis colon cancer. Dr. Amos has developed novel statistical approaches for gene-environment interaction analysis and for the identification of genes influencing complex diseases using either association based approaches or genetic linkage analysis.
              • Kenneth Buetow, PhD, FACMI
                Director of Computational Sciences and Informatics program for Complex Adaptive Systems and Professor in the School of Life Sciences, Arizona State University
                Biography
                  Dr. Ken Buetow is a human genetics and genomics researcher who leverages computational tools to understand complex traits such as cancer, liver disease, and obesity. Dr. Buetow currently serves as Director of Computational Sciences and Informatics program for Complex Adaptive Systems at Arizona State University (CAS@ASU) and is a professor in the School of Life Sciences in ASU's College of Liberal Arts and Sciences. CAS@ASU applies systems approaches that leverage ASU's interdisciplinary research strengths to address complex global challenges. The Computational Sciences and Informatics program is developing and applying information technology to collect, connect, and enhance trans-disciplinary knowledge both within ASU and across the broader knowledge-generating ecosystems. CAS@ASU is creating a Next Generation Cyber Capability to address the challenges and opportunities afforded by "Big Data" and the emergence of 4th Paradigm Data Science. This capability brings state-of-the-art computational approaches to CAS@ASU's transdisciplinary, use-inspired research efforts Dr. Buetow previously served as the Director of the Center for Biomedical Informatics and Information Technology within the National Institutes of Health's National Cancer Institute (NCI). In that capacity he initiated and oversaw the NCI's efforts to connect the global cancer community through community-developed, standards-based, interoperable informatics capabilities that enable secure exchange and use of biomedical data. Buetow designed and built one of the largest biomedical computing efforts in the world. He was responsible for coordinating biomedical informatics and information technology at the NCI. The NCI center he led focused on speeding scientific discovery and facilitated translational research by coordinating, developing and deploying biomedical informatics systems, infrastructure, tools and data in support of NCI research initiatives.
                • Yue Wan, PhD
                  GIS fellow, Genome Institute of Singapore, A*STAR, Genome Institute of Singapore
                  Biography
                    Yue Wan received her B.Sc in Cell Biology and Biochemistry from the University of California, San Diego. She obtained her Ph.D in Cancer Biology  Stanford University, California, USA, under the mentorship of Howard Y. Chang.  During her PhD, she developed the first high-throughput method for probing RNA structures genome-wide.  Yue is a recipient of the NSS-PhD scholarship from Agency for Science, Technology and Research (A*STAR) in Singapore.  She is currently a GIS fellow in the Genome Institute of Singapore and a Society in Science- Branco Weiss Fellow.  Yue is interested in studying functional RNA structures and understanding their roles in regulating cellular biology.
                  • Piero Carninci, PhD
                    Director, Division of Genomic Technologies, RIKEN Center for Life Science Technologies
                    Biography
                      Born and Educated in Italy he obtained his doctoral degree at the University of Trieste in 1989. From 1990 to 1995 he developed technologies for DNA extraction and DNA sequencing at Talent, a spin-off biotech. He moved to Japan in 1995 at RIKEN, Tsukuba Life Science center and became tenure researcher in 1997. He has been developing technologies to capture full-length cDNAs, which were used for the construction of the Fantom projects. Between 2008 and 2013, he was a Team and Unit Leader and a Deputy Project Director at the RIKEN Omics Science Center in Yokohama. He has developed technologies to analyze the the transcribed part of the genome (transcriptome), such as the cap-trapper and the CAGE. These technologies have been broadly used in the RIKEN Fantom projects and allowed identifying non-coding RNAs as are the major output of the mammalian genome and providing comprehensive maps of the mammalian promoters. Additionally he developed a miniaturization of CAGE, in order to approach biological problems that for which there is limited amount of starting material. From April in 2013, he is a Director of the Division Genomics Technologies and a Deputy Director of Center for Life Science Technologies, RIKEN. He has published more than 200 papers and book chapters, edited books and is a member of editorial boards of various scientific journals.
                    • Luk H Vandenberghe, PhD
                      Assistant Professor, Harvard Medical School, Assistant Scientist, Schepens Eye Research Institute, Massachusetts Eye and Ear
                      Biography
                        Assistant Professor, Harvard Medical School <br />Assistant Scientist, Schepens Eye Research Institute, Massachusetts Eye and Ear <br />Director, Gene Transfer Vector Core (GTVC) <br />Associate Director, Ocular Genomics Institute (OGI) <br />Investigator, Berman-Gund Laboratory for Retinal Degenerations, Howe Laboratory <br />Affiliate Faculty, Harvard Stem Cell Institute <br /> <br />Luk H. Vandenberghe, PhD, trained as a biochemical engineer through his training at the University in Leuven, Belgium where he later also obtained his doctoral degree in Medical Sciences. Most of his graduate and postdoctoral work was performed at the University of Pennsylvania in Philadelphia in the leading gene therapy laboratories of Carl June, James Wilson, and Jean Bennett. In 2012, Dr. Vandenberghe set up a lab at the Schepens Eye Research Institute and Mass Eye and Ear in Boston where he is Assistant Professor at Harvard Medical School. Currently he is Director of the Grousbeck Gene Therapy Center and Associate Director of the Ocular Genomics Institute, both primarily focused at bringing gene therapies for vision restoration to the clinic. <br /> <br />In previous work Dr. Vandenberghe has co-discovered, developed, and characterized novel serotypes of the adeno-associated virus (including AAV8,9), several of which are now in wide use at preclinical and clinical experimental stages for a host of target tissues and indications. His work has elucidated key insights into the host response of AAV in humans in the context of pre-existing immunity of this virus endemic in humans. Dr. Vandenberghe is a co-founder of a biotechnology company called GenSight Biologics (Paris, France) and named inventor in over a dozen published and pending patents of gene therapy related technologies. <br /> <br />The Vandenberghe lab at Harvard studies gene therapy approaches for neurosensory disorders with a focus on clinical programs for retinal dystrophies. Its broader ambition is to make gene therapy a widely applicable clinical modality in ophthalmology and beyond. Toward this goal his program builds innovative vector technologies to overcome current translational hurdles.&nbsp; His research brings together molecular virology and immunology, synthetic biology, engineering, and medicine in attempt to understand and improve the challenges of the therapeutic potential of in vivo gene transfer. <br />
                      • Colleen Campbell, PhD
                        Assistant Director, University of Iowa - Iowa Institute for Human Genetics
                        Biography
                          Colleen Campbell, PhD, MS, CGC is the Assistant Director of the Iowa Institute of Human Genetics and an Associate in the Department of Otolaryngology at the University of Iowa Carver College of Medicine. Dr. Campbell received her M.S. in human genetics at Sarah Lawrence College. She is an American Board of Genetic Counseling board certified genetic counselor.  Dr. Campbell received her PhD in human genetics at the University of Iowa in 2012 and completed her post-doctoral training in Otolaryngology at the University of Iowa. In 2012 she co-founded the Iowa Institute of Human Genetics, which is responsible for implementing personalized genomic medicine in the state of Iowa.  Dr. Campbell oversees the Iowa Institute of Human Genetics clinical exome sequencing test and is the Director of the Iowa Institute of Human Genetics Education Division.  Her interests include implementation of exome and genomic testing in the clinical setting, including patient choice of secondary findings. Dr. Campbell is also interested promoting genetic counseling within the state and is the current chair of the NSGC Personalized Medicine Special Interest Group Whole Genome/Whole Exome Sequencing Workgroup, and the incoming Committee Vice Chair for 2015 of the National Society of Genetic Counselors Access Committee.  
                        • Matthew Nesbitt, MSc
                          President, Coastal Genomics
                          Biography
                            Mr. Nesbitt completed his Masters degree in Molecular Biology at Simon Fraser University where his work focused on the discovery of new genes in the C. elegans model organism. This experience impressed upon him both the value of next generation sequencing and its vulnerabilities to the extensively manual sample preparation steps. Mr. Nesbitt started his professional career in liquid handling automation as a product manager responsible for the development of NGS library construction solutions. He now works with Coastal Genomics to launch its automated gel size electrophoresis solution, Ranger Technology. <br />
                          • Heather McLaughlin, PhD, MB(ASCP)CM
                            Clinical Molecular Genetics Fellow, Partners HealthCare Personalized Medicine
                            Biography
                              Dr. McLaughlin is an Assistant Laboratory Director at Partners HealthCare Personalized Medicine's Laboratory for Molecular Medicine. She received a B.S. in Diagnostic Molecular Science from Michigan State University and a Ph.D. in Human Genetics from the University of Michigan. She completed a Clinical Molecular Genetics Fellowship at the Harvard Medical School Genetics Training Program. Dr. McLaughlin's clinical interests focus on molecular diagnostic testing for inherited cardiomyopathies and pulmonary disorders and the implementation of exome and genome sequencing into the clinical laboratory. She is also interested in exploring incidental findings in individuals undergoing genomic sequencing and developing reporting formats that will aid in the integration of genomic sequencing into clinical medicine.
                            • Matthew Lebo, PhD, FACMG
                              Instructor of Pathology, BWH and Harvard Medical School,  Assistant Laboratory Director and Senior IS Domain Specialist Laboratory for Molecular Medicine, Partners HealthCare Center for Perso
                              Biography
                                Matthew Lebo is a trained computational biologist and ABMG-certified clinical molecular geneticist whose work focuses on using statistical and algorithmic approaches to analyze high-throughput data and to bridge genetics with computational and IT systems. Dr. Lebo is currently an Instructor of Pathology at Harvard Medical School and Brigham and Woman's Hospital, where he is developing pipelines to implement whole-genome sequencing data as a clinical test, including methods to analyze, interpret, and report identified genetic variation. Dr. Lebo serves as an Assistant Laboratory Director at the Laboratory for Molecular Medicine (LMM) and as a Senior IS Domain Specialist, both within the Partners Center for Personalized Genetic Medicine (PCPGM). As a director in a clinical diagnostics laboratory, he is responsible for the interpretation and reporting of large gene panel tests - with a special focus in cardiomyopathy - and the development of next-generation sequencing tests, including clinical genome/exome sequencing. As a member of the IT team at PCPGM, Dr. Lebo also works on the development of GeneInsight Suite, an innovative software platform for molecular laboratories, clinics, and EHR systems that manages variant, gene, and disease annotations and the integration of that information into patient reports.
                              • Gary Schroth,PhD
                                Vice President and Distinguished Scientist Illumina
                                Biography
                                  Dr. Schroth is currently a Vice President and Distinguished Scientist at Illumina where he directs the Core Applications Group based in San Diego. He obtained his Ph.D. in biochemistry from the University of California at Davis and has been working in the field of next-generation sequencing (NGS) for more than a decade as part of Illumina (and Solexa). In his research Dr. Schroth uses NGS to study genomics, gene structure, expression and regulation and applies this to genomic projects in the fields of cancer, microbiology and infectious disease. Over the course of his career Dr. Schroth has published over 90 peer reviewed research papers and holds 17 U.S. patents.
                                • Iwijn De Vlaminck, PhD
                                  Postdoctoral researcher, HHMI research associate, Departments of Bioengineering and Applied Physics, Stanford University
                                  Biography
                                    Iwijn De Vlaminck obtained a PhD from the KuLeuven in Belgium. He has a background in applied physics, specifically in nanoscale optics and mechanics. After his PhD he joined the lab of Cees Dekker at the TUDelft as a postdoc in single-molecule biophysics. He joined the lab of Stephen Quake at Stanford University as a postdoctoral researcher in 2012. His current interests include single-cell genomics and sequencing-based medical diagnostics.  
                                  • Matthew Keyser, MS
                                    Senior Manager, NGS Applications, DNASTAR
                                    Biography
                                      Matthew Keyser is Senior Manager, NGS Applications for DNASTAR, where he has helped scientists address their sequence assembly and analysis challenges for the past seven years. Matts sole focus at DNASTAR is supporting customers in next-gen sequencing applications using DNASTARs broad software toolset. Matt helps customers with their templated and de novo assembly projects, transcriptomes, exomes, metagenomic assemblies, RNA-Seq, ChIP-Seq and numerous other unique experiments. Matt has helped hundreds of scientists optimize their workflows using DNASTARs next-gen software solutions. He has also spoken at numerous conferences and workshops regarding the capabilities of DNASTARs next-gen software tools.
                                    • Robert Nussbaum, MD
                                      Clinical Professor, UCSF School of Medicine; Chief Medical Officer, Invitae Corp
                                      Biography
                                        Dr. Robert L. Nussbaum, a board certified internist and medical geneticist, specializes in the care of adults with hereditary disorders. He was previously chief of Genomic Medicine at UCSF Medical Center and co-director of the Program in Cardiovascular Genetics at the UCSF Heart and Vascular Center, which cares for patients with inherited disorders of heart muscle, heart rhythm and large arteries, such as the aorta. Nussbaum is a physician and clinical geneticist with an intense interest in molecular genetics testing and its role in the provision of medical care and disease prevention. He carried out research for over 35 years in the area of cell biology of phosphoinositides and neurodegenerative disease due to abnormalities in alpha-synuclein.
                                      • John Glass, PhD
                                        Senior Scientist, Synthetic Biology Group, J. Craig Venter Institution
                                        Biography
                                          John Glass is a Professor in and leader of the JCVI Synthetic Biology and Bioenergy Group.  His expertise is in molecular biology, microbial pathogenesis, RNA virology, and microbial genomics. Glass is part of the Venter Institute team that created a synthetic bacterial cell in 2010. In reaching this milestone the Venter Institute scientists developed the fundamental techniques of the new field of synthetic genomics including genome transplantation and genome assembly.  Glass was also leader of the JCVI project that rapidly made synthetic influenza virus vaccine strains in collaboration with Novartis Vaccines and Diagnostics, Inc. and Synthetic Genomics, Inc. At the JCVI he has also led the bacterial outer membrane vesicle based vaccine, genome transplantation, and Mycoplasma genitalium minimal genome projects, and projects studying other mycoplasma and ureaplasma species. Glass and his Venter Institute colleagues are now using synthetic biology and synthetic genomics approaches developed at the JCVI to create cells and organelles with redesigned genomes to make microbes that can produce biofuels, pharmaceuticals, and industrially valuable molecules. Prior to joining the JCVI in 2003, Glass spent five years in the Infectious Diseases Research Division of the pharmaceutical company Eli Lilly. There he directed a hepatitis C virology group and a microbial genomics group.Glass earned his undergraduate and graduate degrees from the University of North Carolina at Chapel Hill. His Ph.D. work was on RNA virus genetics in the laboratory of Gail Wertz. He was on the faculty and did postdoctoral fellowships in the Microbiology Department of the University of Alabama at Birmingham in polio virology with Casey Morrow and mycoplasma pathogenesis with Gail Cassell (1990-1998). On sabbatical leave in Ellson Chen's lab at Applied Biosystems Inc.(1995-1997) he sequenced the genome of Ureaplasma parvum and began his study of mycoplasma genomics.
                                        • John Quackenbush, PhD
                                          Professor of Computational Biology and Bioinformatics, Department of Biostatistics, Harvard University, Dana-Farber Cancer Institute
                                          Biography
                                            John Quackenbush received his PhD in theoretical physics from UCLA in 1990. Following a physics postdoc, he received a Special Emphasis Research Career Award from the National Center for Human Genome Research to work on the Human Genome Project, spending two years at the Salk Institute and two years at Stanford University working in genomics and computational biology. In 1997 he moved to The Institute for Genomic Research (TIGR), pioneering expression analysis. He joined the Dana-Farber Cancer Institute and the Harvard School of Public Health in 2005, and works reconstruction of gene networks that drive the development of diseases. In 2012 he and Mick Correll co-Founded GenoSpace, a company that develops software tools to enable precision medicine applications. <br />
                                          • Padma Sundar, MBA, MPH
                                            Director of OncoScan Product Marketing Strategy, Affymetrix
                                            Biography
                                              Padma led the design, development and commercialization of the OncoScan Assay kit, a whole genome copy number platform with high resolution in ~900 cancer genes, that requires  80ng of input DNA from formalin fixed paraffin embedded (FFPE) samples such as those from biopsies. .  The OncoScan Assay has been used extensively for Translational research  in the Academic and Pharma settings,  resulting in over 100 publications in the last two years.. Several labs including the Memorial Sloan Kettering Cancer Center, Fox Chase Cancer Center, ARUP labs and Seattle Cancer Care have launched the OncoScan Assay as a CLIA validated testWorking closely with researchers at leading cancer hospitals worldwide such as at the MD Anderson Cancer Center, Washington Unoversity, and the Hunstsman Cancer Institute,, Padma has designed clinical studies that have successfully demonstrated the clinical utility of the OncoScan Assay in identifying actionable copy number alterations in solid tumor samples. These studies have been presented at  webinars hosted by Science, The European College of Pathology, the Cancer Genomic Consortium, The American Society of Human Genetics among others.    In partnership with CollabRx, a cloud based data analytics company, Padma helped develop a copy number annotation service that  delivers concise, real time information on therapeutics targeting CNVs in cancer patients, with a 24 hour turnaround. This report can be integrated with somatic mutations, such as those from Next generation sequencing panels, Prior to joining Affymetrix, Padma Sundar worked for over 13 years in the Life Sciences industry in Business development roles  at Johnson and Johnson,  Medical Device and Diagnostics Division, and has served various Pharmaceutical clients as a management consultant with McKinsey & Company.She has a Bachelors in Chemistry from the University of Delhi, India and an MBA and a Masters in Public Health from University of California at Berkeley
                                            • Michael C Jewett, PhD
                                              Assistant Professor of Chemical and Biological Engineering, Northwestern University
                                              Biography
                                                Michael Jewett is an Assistant Professor of Chemical and Biological Engineering and Member of the Chemistry of Life Processes Institute at Northwestern University. He received his PhD in 2005 at Stanford University.  After completing postdoctoral studies as an NSF International Research Fellow at the Center for Microbial Biotechnology in Denmark and as an NIH Pathway to Independence Fellow at the Harvard Medical School, he joined Northwestern in 2009.  Mike is developing cell-free biology as an enabling technology for biomanufacturing lifesaving therapeutics, sustainable chemicals, and novel materials, both quickly and on-demand. He focuses on designing, constructing, and modifying biological systems involved in protein synthesis and metabolism, with promise to advance new paradigms for synthetic biology. In 2011, he was honored with a David and Lucile Packard Fellowship in Science and Engineering, the DARPA Young Faculty Award, and the Agilent Early Career Professor Award.
                                              • Jessica C Mar, PhD
                                                Assistant Professor, Department of Systems &amp; Computational Biology, Assistant Professor, Department of Epidemiology &amp; Population Health, Albert Einstein College of Medicine
                                                Biography
                                                  Jessica Mar is an Assistant Professor at the Albert Einstein College of Medicine in the Department of Systems and Computational Biology in the Bronx, New York. The Mar lab investigates how variability of gene expression informs our understanding of how genes and pathways are dysregulated in disease. Dr. Mar received her PhD in Biostatistics from Harvard University in 2008. Previously she was a postdoctoral research fellow at the Dana-Farber Cancer Institute in Boston and a visiting scientist at the European Bioinformatics Institute in the United Kingdom. She is a recipient of a University of Queensland medal and an American-Australian Fulbright award. She is currently an Associate Editor of Genomics.
                                                • Shawn Baker, PhD
                                                  CEO, CSO and Co-Founder, AllSeq, Inc.
                                                  Biography
                                                    Dr. Shawn C. Baker is the Chief Science Officer and co-founder of AllSeq. Having received his Ph.D. at the University of California - Davis, he started his career as a Research Scientist at Illumina when it was a 15-person startup. After spending several years at the bench developing gene expression array products, he transitioned to Product Marketing where he led a team in charge of Illuminas Expression and Regulation sequencing portfolio. In 2013 Dr. Baker co-founded AllSeq, establishing the only true sequencing marketplace, matching researchers with service providers based on their needs. <br />
                                                  • Ellen T Matloff, MS, CGC
                                                    Founder and CEO, Gene Counsel
                                                    Biography
                                                      Ellen T. Matloff, M.S., C.G.C., received her Bachelor's degree in Biology from Union College, her Master's degree in Genetic Counseling from Northwestern University, and her board certification from the American Board of Genetic Counseling.  Matloff was the Founder and Director of the Cancer Genetic Counseling Program at Yale School of Medicine until July 2014 and is the Founder and CEO of Gene Counsel (mygenecounsel.com). Her interests include patient and provider issues in genetic counseling, adverse events in genetic testing and the impact of patents on clinical practice. Ms. Matloff was a lead plantiff in the 2013 Supreme Court case against gene patenting.
                                                    • Dani Bercovich, PhD
                                                      Professor, Scientific Director, Head of MSc program in Biotechnology, Tel Hai College, GGA - Galil Genetic Analysis
                                                      Biography
                                                        Prof' Bercovich expertise are the specialization in preforming complex genetic screening in humans genomic DNA, which were acquired during his post-doctoral in the Baylor College of Medicine, Houston, Texas, which was  one of the five major human genome project centers. When the genomic location of a genomic component (loci - gene) is unknown, Prof; Bercovich is  assisted by using linkage testing techniques (genetic chips with SNP) and then using the techniques of sequencing of the entire EXOM to reveal new genes for human diseaseNew gene mutations, which were identified in laboratory studies of Prof. Bercovich, were used for intracellular studies in the laboratory, and identified the biological effects of those changes. Professor Bercovich working in recent years to develop new diagnostic methods using genetic chips and has resulted in the development stages and final clinical validation of genetic chips for prenatal screening and common mutations which defend predisposition peoples to genetic diseases & cancers, using the Fluidigm nano-chips, by careful planning using higher density of nanometers Taqman reactions. The combination of advances in genetics research in general and human genetics in particular, and the development of various techniques of laboratory tests, led the field of bioinformatics as a center stage to preform quality of laboratory work, and this is a key process in today's medical interpreting test results in research, and in medical services. Professor Bercovich bought himself a place in recent years, to be one of the leading groups in this country; he acquired vast experience in the field and is considered a noticeable expert in the field of molecular Genetics.Prof' Bercovich has publish of 60 pear review articles in high impact factors journals including The Lancet (Bercovich et al Lancet, 2008).
                                                      • Heidi C Howard, PhD
                                                        Senior Researcher, Uppsala University, Centre for Research Ethics &amp; Bioethics
                                                        Biography
                                                          Heidi Carmen Howard is a senior researcher at the Centre for Research Ethics and Bioethics at Uppsala University (Sweden).She received her undergraduate and doctoral degrees in Biology from McGill University (Montréal, Canada). The focus of her PhD was neurogenetics and she continued her genetics training in psychiatric genetics at the Centre for Genomic Regulation in Barcelona (Spain) and at the Douglas Hospital in Montréal (Canada). With an Erasmus Mundus fellowship, she completed the Erasmus Mundus Master of Bioethics programme in 2008. She then spent four years with the support of the European Commission FP7 Marie Curie Career Development Awards (2009-2011; 2011-2013) which allowed her to work on the ethical, legal and social issues (ELSI) related to genetics and genomics as well as biobanking at KULeuven (Belgium) and inserm (France) respectively.Currently, her main areas of research are the ELSI of risk information in genetics and genomics, direct-to-consumer genetic testing, public health genomics, new genomic technologies, participant-centric research initiatives and the translation of genomics from the laboratory to the clinic.Dr. Howard is also an invited scholar at the Centre of Genomics and Policy at McGill University and a member of the Public and Professional Policy Committee of the European Society of Human Genetics.
                                                        • David E Symer, MD, PhD
                                                          Assistant Professor Department of Molecular Virology, Immunology and Medical Genetics, Assistant Professor, Division of Hematology, Department of Internal Medicine, Human Cancer Genetics Prog
                                                          Biography
                                                            Dr. David Symer is an assistant professor in the Human Cancer Genetics Program, Department of Molecular Virology, Immunology and Medical Genetics and Department of Internal Medicine, Division of Hematology at the Ohio State University Comprehensive Cancer Center - James Cancer Hospital. Recently, Dr. Symer also was named interim director of the core laboratory offering shared resources in genomics at Ohio State, the Nucleic Acids / Microarray Shared Resource. Dr. Symer has ongoing research interests in molecular biology and in cancer genetics and genomics. His primary clinical interest is chronic lymphocytic leukemia. He graduated with an AB degree in mathematics from Dartmouth College, earned his MD and PhD degrees at Johns Hopkins University School of Medicine, did his residency at Brigham and Women's Hospital (Harvard Medical School), and completed his fellowship training at Brigham and Women's Hospital and Johns Hopkins Oncology Center. Dr. Symer was a principal investigator at the National Cancer Institute prior to moving to Ohio State in 2009.
                                                          • Jonas Korlach, PhD
                                                            Chief Scientific Officer, Pacific Biosciences
                                                            Biography
                                                              Jonas Korlach was appointed Chief Scientific Officer of Pacific Biosciences in July 2012. He was previously a Scientific Fellow, supporting commercial development of the PacBio RS II system and performing research aimed at developing new applications for SMRT technologies. He co-invented the SMRT technology with Stephen Turner, Ph.D., Pacific Biosciences Founder and Chief Technology Officer, when the two were graduate students at Cornell University. Dr. Korlach joined Pacific Biosciences as the company's eighth employee in 2004. Previously, he was a Postdoctoral Researcher at Cornell University. Dr. Korlach is the recipient of multiple grants, an inventor on 70 issued U.S. patents and 61 international patents, and an author of over 70 scientific studies on the principles and applications of SMRT technology, including publications in Nature, Science, and PNAS. In 2013, Dr. Korlach was honored by the Obama White House as an Immigrant Innovator "Champion of Change." He received both his Ph.D. and his M.S. degrees in Biochemistry, Molecular and Cell Biology from Cornell, and received M.S. and B.A. degrees in Biological Sciences from Humboldt University in Berlin, Germany.
                                                            • Mark B Gerstein, PhD
                                                              Albert L. Williams Professor of Biomedical Informatics, Co-Director, Yale Computational biology and Bioinformatics Program, Yale University
                                                              Biography
                                                                  Mark Gerstein is the Albert L Williams professor of Biomedical Informatics at Yale University. He is co-director the Yale Computational Biology and Bioinformatics Program, and has appointments in the Department of Molecular Biophysics and Biochemistry and the Department of Computer Science. He received his AB in physics summa cum laude from Harvard College and his PhD in chemistry from Cambridge. He did post-doctoral work at Stanford and took up his post at Yale in early 1997. Since then he has published appreciably in scientific journals. He has >400 publications in total, with a number of them in prominent journals, such as Science, Nature, and Scientific American. (His current publication list is at http://papers.gersteinlab.org .) His research is focused on bioinformatics, and he is particularly interested in large-scale integrative surveys, biological database design, macromolecular geometry, molecular simulation, human genome annotation, gene expression analysis, and data mining.     
                                                              • Gordon B Mills, MD, PhD
                                                                Department Chair, Department of Systems Biology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center
                                                                Biography
                                                                  Gordon B. Mills, MD, PhD, was recruited to The University of Texas M. D. Anderson Cancer Center in 1994, where he holds the rank of Professor with joint appointments in Systems Biology, Breast Medical Oncology and Immunology; serves as chairman of the Department of Systems Biology; head of the section of Molecular Therapeutics and holds the Wiess Distinguished University Chair in Cancer Medicine. Dr. Mills is co-Director of the Kleberg Center for Molecular Markers and Director for the Gita and Ali Saberioon Molecular Markers building. This Center is responsible for developing personalized molecular medicine at MDACC. Dr. Mills has published extensively on the molecular analysis of cancer and currently serves as principal investigator or project investigator on many national peer review grants including NIH/NCI SPOREs and PPGs, Department of Defense, and Komen Foundation grants, and is a collaborator on multiple other national grants. Dr. Mills also holds more than 20 patents related to novel technologies and molecular markers and has co-founded an early diagnostics company. He currently sits on the scientific advisory boards of multiple companies and venture capital groups. Based on his expertise in technology development, he is the head of the M. D. Anderson Cancer Center Technology Review Committee.    
                                                                • Joanna Hamilton, PhD, Lynne Apone, PhD, Zach Smith, MS
                                                                  Joanna Hamilton, PhD, Co-Director, Dartmouth Medical School and the Norris Cotton Cancer Center Lynne Apone, PhD, Application and Product Development Scientist, NEBNext group, New England Bi
                                                                  Biography
                                                                    Joanna Hamilton is the Co-Director of the Genomics Shared Resource at Dartmouth Medical School and the Norris Cotton Cancer Center in Lebanon NH.  Dr. Hamilton received her PhD in 2005 in Cancer Biology and completed her post-doc training in Cardiology at Dartmouth.  In 2010, she joined the Genomics Shared Resource and was promoted to Co-Director in 2012.  Dr. Hamilton has been responsible for implementing the deep sequencing services available to researchers and is knowledgeable of both Illumina and Ion Torrent sequencing platforms and microarrays technologies. Dr. Lynne Apone is an Application and Product Development Scientist at New England Biolabs, working in the NEBNext group. Dr. Apone received her PhD in Biomedical Sciences from the University of Massachusetts, Worcester. She remained at UMMC as a Post Doctoral fellow and later, an Instructor. Dr. Apone joined Agencourt Personal Genomics in 2005 as a member of the team tasked to develop the SOLiD next generation sequencing platform. In 2010 she joined New England Biolabs where she focuses on the development of products and applications that enable high throughput sequencing on the Ion Torrent and Illumina platforms. Zach Smith currently serves as a Senior Applications Scientist at Beckman Coulter, Inc. developing applications for next generation sequencing (NGS) and other life science methods on Beckman's BioMek liquid handing robots. Prior to this, Zach served for over eight years as a Project Scientist at the Center for Genomics and Bioinformatics at Indiana University, Bloomington, where he contributed to several large genome sequencing projects including the cladoceran microcrustacean Daphnia pulex , the jewel wasp  Nasonia vitripennis, the lone-star tick Amblyomma americanum, and others.  Zach completed a Bachelor's of Science in Biology from Indiana University in 2002, followed by a Masters of Environmental Science from Indiana University's School of Public and Environmental Affairs in 2012.
                                                                  • Ryan E Mills, PhD
                                                                    Assistant Professor, Department of Computational Medicine &amp; Bioinformatics, Assistant Professor, Department of Human Genetics, University of Michigan
                                                                    Biography
                                                                      Ryan Mills is an Assistant Professor in Computational Medicine & Bioinformatics and Human Genetics at the University of Michigan. After receiving his PhD in 2006 at Georgia Tech, he worked as an NRSA Postdoctoral Fellow at Emory University where he helped produce some of the first published genome-wide maps of insertion/deletion (indel) variation in human populations and develop technologies to derive their genotypes using microarrays. As a Research Associate at Harvard Medical School, he expanded the scope of his work into the mapping of larger structural and copy number variation as part of the 1000 Genomes and other projects. His current research is focused on developing methods for the identification, resolution and analysis of complex genomic rearrangements consisting of multiple breakpoints that are the result of overlapping or co-occurring structural changes to the genome.
                                                                    • Vikram Devgan, PhD, MBA
                                                                      Director, Head of Biological research content, Qiagen, Inc.
                                                                      Biography
                                                                        Dr. Devgan is the head of the Biological Research Content, QIAGEN. He received his Ph.D. in molecular biology and conducted post-doctoral research at Harvard Medical School before moving to the biotechnology industry. He received his MBA from the University of Wurzburg in Germany and has spent many years as a scientist in developing new technologies and products clinical and translational research.
                                                                      • Sohela Shah, PhD
                                                                        Field Application Scientist, Ingenuity Systems, a Qiagen company, Neihaus research fellow, Memorial Sloan Kettering Cancer Center
                                                                        Biography
                                                                          Sohela has a PhD in genetics from the Sackler School of Biomedical Sciences at Tufts University. After completing her postdoc in Human Genetics at University of California San Francisco, she joined Memorial Sloan Kettering Cancer Center as Neihaus fellow. She came to Ingenuity in 2013 as a Field Application Scientist.
                                                                        • Cecile Janssens, PhD
                                                                          Research Professor of Epidemiology, Emory University
                                                                          Biography
                                                                            Cecile Janssens is professor of translational epidemiology in the department of Epidemiology of the Rollins School of Public Health, Emory University, Atlanta, USA. Her research concerns the translation of genomics research to applications in clinical and public health practice. Her work focuses on the prediction of multifactorial diseases (e.g. diabetes, cardiovascular disease, asthma) using genetic risk models and on the assessment of the predictive ability and utility of genetic testing. She recently co-chaired a workshop that developed reporting guidelines for genetic risk prediction studies, the GRIPS Statement, and chaired a workshop for the European Commission that proposed quality criteria for health checks. Cecile Janssens has published over 150 papers in international scientific journals. She is a lecturer in graduate and post-graduate courses in local, national and international programs, and coordinates a summer course on Translational Research in Genomic Medicine at Emory. Before moving to the USA, she was chair of the Dutch Association of Community Genetics and Public Health Genomics and board member of the Netherlands Association for Human Genetics. She still is an active member of the Health Council of the Netherlands.  
                                                                          Sponsored By

                                                                          For information on becoming a sponsor or exhibitor, please click here.


                                                                          Continuing Education (CME/CE/CEU) Credits

                                                                          The speakers below have been approved for CME, CE, or CEU credits. To redeem your credits, locate the presentation you watched and click on the CME/CE/CEU buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


                                                                          Committee

                                                                          To download the Program Committee brochure here.


                                                                          • Alan Wright, MD

                                                                            Dr. Wright is the Chief Medical Officer at Roche Diagnostics Corporation in Indianapolis, Indiana. Prior to joining Roche, Dr. Wright served as Senior Vice President of Health Improvement Strategies for Miraca Life Sciences. He was the Vice President for Product Strategy and ...

                                                                            See more See less
                                                                          • Ross J Molinaro, PhD, MT(ASCP), DABCC, FACB

                                                                            Ross J. Molinaro, PhD, MT(ASCP), DABCC, FACB is an Assistant Professor in the Department of Pathology and Laboratory Medicine at Emory University. He received his PhD in Clinical Chemistry and Molecular Medicine from Cleveland State University and completed the ComACC training ...

                                                                            See more See less
                                                                          • Paul Mathews, PhD

                                                                            Dr. Paul J. Mathews received his bachelors degree from the University of Oregon where he studied invertebrate behavioral plasticity in the lab of Dr. Nathan Tublitz. He received his Ph.D. in neuroscience from the University of Texas at Austin under the mentorship of Dr. Nace ...

                                                                            See more See less
                                                                          • Tatjana Matejic, PhD, D(ABMLI)

                                                                          • Mark Marzinke, PhD, BABCC

                                                                            Mark Marzinke, PhD, DABCC earned a Ph.D. in Biochemistry from the University of Wisconsin-Madison and subsequently completed a clinical chemistry fellowship at The Johns Hopkins University in 2012. During his clinical fellowship, Dr. Marzinke focused on the development and ...

                                                                            See more See less
                                                                          • Alan Maisel, MD

                                                                            Dr. Alan Maisel attended University of Michigan Medical School and did his cardiology training at the University of California at San Diego. He is currently Professor of Medicine at the University and director of the coronary care unit and the heart failure program at the ...

                                                                            See more See less
                                                                          • Ariel Louwrier PhD

                                                                            Successful Senior Scientific Business Executive with demonstrated expertise growing markets, revenues, product pipelines and expanding technical organizations into new business opportunities. Educational and business management experience in global markets, with quantified ...

                                                                            See more See less
                                                                          • Martin Latterich, PhD

                                                                            The discovery of proteinaceous disease biomarkers and their clinical validation is critically important for the enablement of molecular diagnostics and ultimately, precision medicine. In spite of the importance of biomarkers, research done in the last two decades has yielded ...

                                                                            See more See less
                                                                          • Fred Russell Kramer, PhD

                                                                          • Kamisha Johnson-Davis, PhD, DABCC, FACB

                                                                            Dr. Johnson-Davis is a medical director of the Clinical Toxicology laboratory, Antifungal Testing and Immunosuppressants Testing at ARUP. Dr. Johnson-Davis received her PhD in pharmacology at the University of Utah and is board certified in clinical chemistry by the American ...

                                                                            See more See less
                                                                          • Daniel Irimia, MD, PhD

                                                                          • Michael Holick, MD, PhD

                                                                            Michael F. Holick, Ph.D., M.D. is Professor of Medicine, Physiology and Biophysics; Director of the General Clinical Research Unit; and Director of the Bone Health Care Clinic and the Director of the Vitamin D, Skin and Bone Research Laboratory at Boston University Medical ...

                                                                            See more See less
                                                                          • Howard Morris, PhD, FAACB, FFSc(RCPA)

                                                                            Professor Howard Morris is Professor of Medical Sciences at the University of South Australia and a Chief Medical Scientist in Chemical Pathology at SA Pathology, Adelaide, South Australia. He is currently Vice-President of the International Federation of Clinical Chemistry ...

                                                                            See more See less
                                                                          • Judd Moul, MD, FACS

                                                                            Judd W. Moul is James H. Semans, MD Professor of Surgery, Division of Urologic Surgery, and Director of the Duke Prostate Center, Duke Cancer Institute at Duke University Medical Center. Prior to joining Duke, he was Professor of Surgery at the Uniformed Services University of ...

                                                                            See more See less
                                                                          • Stephanie Willerth, PhD

                                                                            Dr. Willerth currently holds a Canada Research Chair in Biomedical Engineering at the University of Victoria where she is dually appointed in the Department of Mechanical Engineering and Division of Medical Sciences. Her research group investigates how to engineer neural tissue ...

                                                                            See more See less
                                                                          • Kathryn Wellen, PhD

                                                                          • Bart C. Weimer, PhD

                                                                          • Sihe Wang, PhD DABCC FACB

                                                                            Dr. Sihe Wang is Section Head and Medical Director of Clinical Biochemistry and Director of Clinical Biochemistry Fellowship Training Program, Cleveland Clinic, Cleveland, Ohio. He also chairs the clinical chemistry integration effort for the Cleveland Clinic Health System which ...

                                                                            See more See less
                                                                          • Katerina Venderova, PharmD, PhD

                                                                            Dr. Katerina Venderova obtained her master's and doctorate degrees in pharmacy, and her PhD in Toxicology from Charles University in the Czech Republic. She then received a fellowship from the Parkinson Society Canada and pursued her postdoctoral training at Toronto Western ...

                                                                            See more See less
                                                                          • Leigh Anne Swayne, PhD

                                                                          • Joely Straseski, PhD, MS, MT(ASCP), DABCC

                                                                            Dr. Straseski is a medical director of endocrinology at ARUP Laboratories and an assistant professor of pathology at the University of Utah School of Medicine. She received her PhD in pathology and laboratory medicine and a Master's degree in bacteriology from the University of ...

                                                                            See more See less
                                                                          • Ahmad Salehi, MD, PhD

                                                                            Ahmad Salehi, M.D., Ph.D. is a Clinical Associate Professor at the Department of Psychiatry and Behavioral Sciences, Stanford Medical School and the Director of the Translational Laboratory at the VA Palo Alto Health Care System in California. He obtained his MD in Tehran, Iran ...

                                                                            See more See less
                                                                          • Amy K Saenger, PhD, DABCC, FACB

                                                                          • Andrea Rose, PhD, MBA

                                                                          • James H. Nichols, Ph.D., DABCC, FACB

                                                                          • Bruce Hollis, PhD

                                                                            Bruce W. Hollis, Ph.D. received his B.Sc. and M.Sc. from the Ohio State University and subsequently his Ph.D. from the University of Guelph in 1979. Dr. Hollis then completed an Endocrine Fellowship at The Case Western Reserve University School of Medicine in 1982. Dr. Hollis ...

                                                                            See more See less
                                                                          • Ulrich Hengst, PhD

                                                                            Dr. Ulrich Hengst studied biochemistry at the Ruhr University Bochum, Germany, and conducted his graduate research at the Friedrich Miescher Institute for Biomedical Research in Basel, Switzerland, in the group of Prof. Denis Monard. In 2003 he received his PhD from the ...

                                                                            See more See less
                                                                          • Anthony Grace, PhD

                                                                            Dr. Anthony A. Grace is a Distinguished Professor of Neuroscience and a Professor of Psychiatry and Psychology at the University of Pittsburgh in Pittsburgh, PA. He received his Ph.D. from Yale University School of Medicine with Dr. Benjamin S. Bunney and had postdoctoral ...

                                                                            See more See less
                                                                          • R. Claudio Aguilar, Ph.D.

                                                                            Dr. Aguilar obtained his PhD degree in Immunochemistry from the School of Pharmacy and Biochemistry, University of Buenos Aires, Argentina. Dr. Aguilar pursued his post-doctoral training at the National institutes of Health in Bethesda, MD in the lab of the well-known cell ...

                                                                            See more See less
                                                                          • Theral Timpson

                                                                          • Deanne Taylor, MS, PhD

                                                                            Dr. Taylors background is in biophysics, bioinformatics, computational biology and structural biology with emphasis on human genetics and translational medicine. She obtained her Ph.D. in Biophysics from the University of Michigan, Ann Arbor, and completed a postdoctoral ...

                                                                            See more See less
                                                                          • John Quackenbush, PhD

                                                                            John Quackenbush received his PhD in 1990 in theoretical physics from UCLA working on string theory models. Following two years as a postdoctoral fellow in physics, Dr. Quackenbush applied for and received a Special Emphasis Research Career Award from the National Center for ...

                                                                            See more See less
                                                                          • C Jimmy Lin, MD, PhD, MHS

                                                                            Jimmy Lin, MD, PhD, MHS, is a 2012 TED Fellow and Founder & President of Rare Genomics Institute, the world's first platform to enable any community to leverage cutting-edge biotechnology to advance understanding of any rare disease. Partnering with 18 of the top medical ...

                                                                            See more See less
                                                                          • Agnieszka Lichanzka Ph.D.

                                                                            Agnieszka is currently a Staff Scientist and Laboratory Manager at TessArae, LLC in Sterling, VA, USA. She obtained her PhD at the University of Queensland in Australia in a field of biochemistry, and subsequently worked as a post-doctoral fellow at Queen's University of Belfast ...

                                                                            See more See less
                                                                          • Timothy Harris, PhD

                                                                            Since June 2011, Dr. Harris has served as the Senior Vice President of Translational Medicine at Biogen Idec. Dr. Harris has served as the Director of the Advanced Technology Program at SAIC Frederick since 2007 and Chief Technology Officer for SAIC Frederick since 2008. Prior to ...

                                                                            See more See less
                                                                          • Wieslaw Furmaga, MD

                                                                            Director, Clinical Chemistry Laboratory University Hospital Director, General Laboratory Cancer Treatment Research Center Director, Proteomics Laboratory UTHSC at San Antonio Interim Director, Molecular Laboratory UTHSC at San Antonio Associate Director, Mycology Laboratory UTHSC ...

                                                                            See more See less
                                                                          • Charles Cantor, PhD

                                                                            Dr. Charles Cantor is a founder, and Chief Scientific Officer at SEQUENOM, Inc., which is a genetics discovery company with tools, information and strategies for determining the medical impact of genes and genetic variations. He is also the founder of SelectX Pharmaceuticals ...

                                                                            See more See less
                                                                          • Joan W Bennett, PhD

                                                                          • Pinar Bayrak-Toydemir, MD, PhD

                                                                            Dr. Bayrak-Toydemir is the medical director of the Molecular Genetics and Genomics Laboratories at ARUP and an associate professor of pathology at the University of Utah School of Medicine. Dr. Bayrak-Toydemir received her MD from the Ankara University School of Medicine in ...

                                                                            See more See less
                                                                          • Ottavio Arancio MD, Ph.D

                                                                            Dr. Ottavio Arancio received his Ph.D and M.D. from the University of Pisa (Italy). From 1981 to 1986 he took residency training in Neurology at the University of Verona (Italy). Dr. Arancio has held Faculty appointments at Columbia University, NYU School of Medicine and at ...

                                                                            See more See less
                                                                          • Szczepan Baran, VMD, MS

                                                                            Dr. Szczepan Baran is the Global Head, Animal Welfare and Compliance Training at Novartis Institutes for Biomedical Research. Dr. Baran received a Bachelor of Science in Pre-Veterinary Medicine from the University of Delaware, a Veterinary Medical Doctoral degree from the ...

                                                                            See more See less
                                                                          • Pierre-Antoine Gourraud, PhD, MPH

                                                                            Pierre-Antoine Gourraud is a former student of the Ecole Normale Suprieure de Lyon in France. After receiving an M.P.H. from University Paris XIII in 2002, he got his Ph.D. in Immunogenetic Epidemiology and Public Health from Toulouse University in 2005. He relocated to the ...

                                                                            See more See less
                                                                          • Eric Gluck, MD, JD

                                                                          • Sharon Geaghan, MD

                                                                            Dr. Geaghan is Chief, Pathology at Lucile Packard Children's Hospital at Stanford, and Co-Director of Clinical Laboratories at Stanford Hospital and Clinics. She also directs the Bass Pediatric Cancer Center Laboratory at the Lucile Packard Hospital; is Director of the Point of ...

                                                                            See more See less
                                                                          • George Fritsma, MS, MT

                                                                            George Fritsma is an associate professor in Laboratory Medicine of the Department of Pathology at the University of Alabama at Birmingham. Prof. Fritsma manages www.fritsmafactor.com, "The Fritsma Factor, Your Interactive Hemostasis Resource," a clinical coagulation ...

                                                                            See more See less
                                                                          • Bradley Ford, MD, PhD

                                                                            Bradley Ford received his M.D. and Ph.D. (Physiology and Biophysics) degrees from SUNY Stony Brook, followed by a Clinical Pathology residency and postdoctoral training in basic and clinical microbiology at Washington University in St. Louis. His research interests include ...

                                                                            See more See less
                                                                          • David Carpentieri, MD

                                                                          • Cynthia Bowman MD

                                                                            Dr. Cynthia Bowman has been a broad based general pathologist for over 30 years. She graduated with a BA in Chemistry from St. Olaf College, received her MD from Vanderbilt University Medical School, and trained for 6 years at the University of California, San Francisco as a ...

                                                                            See more See less
                                                                          • Christoph H. Borchers, Ph.D.

                                                                            Dr. Borchers received his B.S., M.S. and Ph.D. from the University of Konstanz, Germany. After his post-doctoral training and employment as a staff scientist at NIEHS/NIH/RTP, NC and he was the director of the Duke - UNC Proteomics Facility and held a faculty position at UNC ...

                                                                            See more See less
                                                                          • Josip Blonder, MD

                                                                            Dr. Blonder leads the Clinical Proteomics Group at the CRTP/FNL. FNL is a Federally Funded Research and Development Center operated by Leidos Biomedical Research, Inc., for the National Cancer Institute (NCI). In 1978, Dr. Blonder received his M.D. at the Rijeka University ...

                                                                            See more See less
                                                                          • Peter Blume-Jensen, MD, PhD

                                                                            Dr. Peter Blume-Jensen has extensive expertise in basic and translational cancer research, oncogenic signaling, and targeted oncology therapeutics drug discovery prior to joining Metamark as CSO in 2010.&nbsp; From 2001 to 2008 Peter was department head at first Serono, US and ...

                                                                            See more See less
                                                                          • Antonio Baines, PhD

                                                                            Dr. Antonio T. Baines is an Associate Professor in the Department of Biology at North Carolina Central University (NCCU) and an adjunct professor in the Department of Pharmacology in the School of Medicine at the University of North Carolina (UNC) Chapel Hill. He earned a ...

                                                                            See more See less
                                                                          • Vincent Mauro, Ph.D.

                                                                            Dr. Mauro is an Associate Professor in the Department of Neurobiology at the Scripps Research Institute in La Jolla, California. He is also a co-founder and lead scientist of Promosome, a biotechnology company focused on bioproduction enablement and DNA vaccines. In addition, Dr ...

                                                                            See more See less
                                                                          Help

                                                                          General LabRoots Questions

                                                                          For bugs, spam, technical support or questions please call +1-714-463-4673 or email support@labroots.com  
                                                                          Contact us

                                                                          Virtual Events and Webinars

                                                                          Supported Configurations

                                                                          • Operating System Internet Explorer Firefox Chrome Safari
                                                                            Vista IE8+ FF10+ Chrome15+
                                                                            Windows 7 IE8+ FF10+ Chrome15+
                                                                            Windows 8 IE10 FF10+ Chrome15+
                                                                            Mac OS X   FF10+ Chrome15+ Safari5.1+
                                                                          • Cookie settings: session cookies enabled
                                                                          • Browser configuration must have JavaScript enabled
                                                                          • Adobe Flash player 10.2 or later

                                                                          To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                                                                          Internet Connection

                                                                          • A minimum of 100Kbps is recommended for audio-only events
                                                                          • A minimum of 300Kbps is recommended for speaker on-video events

                                                                          Computer Equipment

                                                                          • Screen Resolution: Minimum 1024x768
                                                                          • Video Card: 65,000 colors minimum
                                                                          • Sound card and speakers (or headphones) for hearing webcast in full format
                                                                          • Audio Card: 16-bit minimum
                                                                          • RAM: 512MB of free RAM

                                                                          Firewall Protocol

                                                                          • HTTP on port 80 or HTTPS on port 443
                                                                          • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                                                                          • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                                                                          Work-At-Home Attendees

                                                                          • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                                                                          For A Seamless Experience

                                                                          When using a mobile device, FREE Mobile Apps are available:

                                                                          - For viewing Webinars:

                                                                          - For viewing Virtual Events

                                                                          Attendee Guide

                                                                          • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                                                                          Virtual Event and Webinar Support:

                                                                          Continuing Education (CME/CE) Support

                                                                          Loading Comments...
                                                                          Show Resources